Fjarde Ap Fonden Teva Pharmaceutical Industries LTD Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Fjarde Ap Fonden holds 303,950 shares of TEVA stock, worth $6.92 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

303,950

Previous 368,323 17.48%

Holding current value

$6.92 Million

Previous $5.2 Million 5.39%

% of portfolio

0.06%

Previous 0.06%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$15.81 - $18.96 $1.02 Million - $1.22 Million	-64,373 Reduced 17.48%	303,950 $5.48 Million
Q1 2024 Apr 25, 2024	BUY	$10.67 - $14.43 $66,879 - $90,447	6,268 Added 1.73%	368,323 $5.2 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $88,386 - $115,707	10,885 Added 3.1%	362,055 $3.78 Million
Q3 2023 Oct 23, 2023	BUY	$7.48 - $10.7 $138,522 - $198,153	18,519 Added 5.57%	351,170 $3.58 Million
Q2 2023 Aug 02, 2023	BUY	$7.2 - $9.47 $1.26 Million - $1.65 Million	174,700 Added 110.6%	332,651 $2.5 Million
Q1 2023 May 15, 2023	SELL	$8.36 - $11.37 $272,109 - $370,082	-32,549 Reduced 17.09%	157,951 $1.4 Million
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $1.27 Million - $1.51 Million	-159,500 Reduced 45.57%	190,500 $1.74 Million
Q4 2021 Feb 15, 2022	BUY	$7.9 - $10.19 $1.19 Million - $1.53 Million	150,000 Added 75.0%	350,000 $2.8 Million
Q2 2018 Jul 12, 2018	BUY	$16.77 - $24.71 $3.35 Million - $4.94 Million	200,000 New	200,000 $4.86 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account